The Malaysian Organization of Pharmaceutical Industries (MOPI) forecasts the country’s pharmaceutical industry to grow 10% to MYR 9.3 billion ($1.1 billion) this year. Fueling the growth is demand related to the H1NI virus. The generic drug manufacturing industry makes up 35% of the domestic market and is estimated to grow 15% due to growth in the domestic and export markets. Generic drug exports, which go to 43 nations, total around MYR 200 million per year. Exports are expected to growth 15%–30% over three years. Another growth driver is contract manufacturing.

Source: The Star Online